• Join
  • Login
  • Contact

Search abstracts

The evaluation of pharmacoeconomics of thiazolidinedione class of antidiabetic agents-a retrospective study

  • At: Beijing (China) (2007)
  • Type: Poster
  • By: HUANG, Chiu-Ku (Tainan Municipal Hospital, Tainan, China Taiwan)
  • Co-author(s): Wang, Er-Ting (Tainan Municipal Hospital, Tainan, China Taiwan)
  • Abstract:

    Aim: The drugs to ameliorate insulin resistance are PPAR-g(peroxisome proliferator-activated receptor-g), including rosiglitazone and pioglitazone in Taiwan. The class of hypoglycemic agents was approved to decrease HbA1C, elevate HDL and decrease glucose level in patients with type 2 DM in clinical trials, which following time are about half


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses